IBDEI1AV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20786,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,20786,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,20786,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,20787,0)
 ;;=F02.80^^95^1023^55
 ;;^UTILITY(U,$J,358.3,20787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20787,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,20787,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,20787,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,20788,0)
 ;;=G31.84^^95^1023^66
 ;;^UTILITY(U,$J,358.3,20788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20788,1,3,0)
 ;;=3^Mild Neurocog D/O w/ LEWY BODIES
 ;;^UTILITY(U,$J,358.3,20788,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,20788,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,20789,0)
 ;;=F02.81^^95^1023^30
 ;;^UTILITY(U,$J,358.3,20789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20789,1,3,0)
 ;;=3^Major Neurocog D/O d/t MULTIPLE ETIOLOGIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,20789,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,20789,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,20790,0)
 ;;=F02.80^^95^1023^31
 ;;^UTILITY(U,$J,358.3,20790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20790,1,3,0)
 ;;=3^Major Neurocog D/O d/t MULTIPLE ETIOLOGIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,20790,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,20790,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,20791,0)
 ;;=G31.84^^95^1023^61
 ;;^UTILITY(U,$J,358.3,20791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20791,1,3,0)
 ;;=3^Mild Neurocog D/O d/t MULTIPLE ETIOLOGIES
 ;;^UTILITY(U,$J,358.3,20791,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,20791,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,20792,0)
 ;;=G90.3^^95^1023^67
 ;;^UTILITY(U,$J,358.3,20792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20792,1,3,0)
 ;;=3^Multi-System Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,20792,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,20792,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,20793,0)
 ;;=F02.81^^95^1023^38
 ;;^UTILITY(U,$J,358.3,20793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20793,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,20793,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,20793,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,20794,0)
 ;;=F02.80^^95^1023^39
 ;;^UTILITY(U,$J,358.3,20794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20794,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,20794,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,20794,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,20795,0)
 ;;=F02.81^^95^1023^44
 ;;^UTILITY(U,$J,358.3,20795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20795,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,20795,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,20795,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,20796,0)
 ;;=F02.80^^95^1023^45
 ;;^UTILITY(U,$J,358.3,20796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20796,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,20796,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,20796,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,20797,0)
 ;;=G31.84^^95^1023^62
 ;;^UTILITY(U,$J,358.3,20797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20797,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
